510 related articles for article (PubMed ID: 15017666)
1. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
[TBL] [Abstract][Full Text] [Related]
2. Endoluminal therapy for Barrett's with high-grade dysplasia and early esophageal adenocarcinoma.
Ginsberg GG
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):241-5. PubMed ID: 15017662
[No Abstract] [Full Text] [Related]
3. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
[TBL] [Abstract][Full Text] [Related]
4. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
5. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques.
May A; Gossner L; Pech O; Müller H; Vieth M; Stolte M; Ell C
Endoscopy; 2002 Aug; 34(8):604-10. PubMed ID: 12173079
[TBL] [Abstract][Full Text] [Related]
6. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
7. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Devière J
Endoscopy; 2002 Dec; 34(12):950-5. PubMed ID: 12471537
[TBL] [Abstract][Full Text] [Related]
10. Molecular evaluation of ablative therapy of Barrett's oesophagus.
Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
[TBL] [Abstract][Full Text] [Related]
11. High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.
Thomas T; Richards CJ; de Caestecker JS; Robinson RJ
Aliment Pharmacol Ther; 2005 Mar; 21(6):747-55. PubMed ID: 15771761
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
13. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
14. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE
Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
[TBL] [Abstract][Full Text] [Related]
15. [Endoscopic argon plasma coagulation of Barrett mucosa].
Brand B; Porthun M; von Schrenck T; Matsui U; Bohnacker S; Jäckle S; Thonke F; Seitz U; Soehendra N
Zentralbl Chir; 2000; 125(5):437-42. PubMed ID: 10929628
[TBL] [Abstract][Full Text] [Related]
16. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
Morris CD; Byrne JP; Armstrong GR; Attwood SE
Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
18. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.
Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW
Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428
[TBL] [Abstract][Full Text] [Related]
19. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation.
Byrne JP; Armstrong GR; Attwood SE
Am J Gastroenterol; 1998 Oct; 93(10):1810-5. PubMed ID: 9772036
[TBL] [Abstract][Full Text] [Related]
20. Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence.
Ferraris R; Fracchia M; Foti M; Sidoli L; Taraglio S; Vigano' L; Giaccone C; Rebecchi F; Meineri G; Senore C; Pera A;
Aliment Pharmacol Ther; 2007 Apr; 25(7):835-40. PubMed ID: 17373922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
